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Racial/ethnic disparities among Asian
Americans in inpatient acute myocardial
infarction mortality in the United States
Eun Ji Kim1*, Nancy R. Kressin2,3, Michael K. Paasche-Orlow2, Lenny Lopez4, Jennifer E. Rosen5, Mengyun Lin2
and Amresh D. Hanchate2,3

Abstract
Background: Acute myocardial infarction (AMI) is a common high-risk disease with inpatient mortality of 5%
nationally. But little is known about this outcome among Asian Americans (Asians), a fast growing racial/ethnic
minority in the country. The objectives of the study are to obtain near-national estimates of differences in AMI
inpatient mortality between minorities (including Asians) and non-Hispanic Whites and identify comorbidities and
sociodemographic characteristics associated with these differences.
Method: This is a retrospective analysis of 2010–2011 state inpatient discharge data from 10 states with the largest
share of Asian population. We identified hospitalization with a primary diagnosis of AMI using the ICD-9 code and
used self-reported race/ethnicity to identify White, Black, Hispanic, and Asian. We performed descriptive analysis of
sociodemographic characteristics, medical comorbidities, type of AMI, and receipt of cardiac procedures. Next, we
examined overall inpatient AMI mortality rate based on patients’ race/ethnicity. We also examined the types of AMI
and a receipt of invasive cardiac procedures by race/ethnicity. Lastly, we used sequential multivariate logistic regression
models to study inpatient mortality for each minority group compared to Whites, adjusting for covariates.
Results: Over 70% of the national Asian population resides in the 10 states. There were 496,472 hospitalizations with a
primary diagnosis of AMI; 75% of all cases were Whites, 10% were Blacks, 12% were Hispanics, and 3% were Asians.
Asians had a higher prevalence of cardiac comorbidities, including hypertension, diabetes, and kidney failure compared
to Whites (p-value< 0.01). There were 158,623 STEMI (ST-elevation AMI), and the proportion of hospitalizations for STEMI
was the highest for Asians (35.2% for Asians, 32.7% for Whites, 25.3% for Blacks, and 32.1% for Hispanics). Asians had
the highest rates of inpatient AMI mortality: 7.2% for Asians, 6.3% for Whites, 5.4% for Blacks, and 5.9% for Hispanics
(ANOVA p-value < 0.01). In adjusted analyses, Asians (OR = 1.11 [95% CI: 1.04–1.19]) and Hispanics (OR = 1.14 [1.09–1.19])
had a higher likelihood of inpatient mortality compared to Whites.
Conclusions: Asians had a higher risk-adjusted likelihood of inpatient AMI mortality compared to Whites. Further
research is needed to identify the underlying reasons for this finding to improve AMI disparities for Asians.
Keywords: Acute myocardial infarction, Mortality, comorbidities, Health disparity, Asian
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Background
Coronary artery disease is a common condition that
affects 15 million adults in the US and about 715,000
people have acute myocardial infarction (AMI) annually
[1]. AMI mortality has been significantly reduced with
advances in care, standardization of AMI management,
and modifications of AMI-related risk factors [2–4].
Despite these improvements, there exist significant racial
and ethnic disparities in the treatment and outcome of
AMI [5–21]. These studies have shown that minorities,
mostly non-Hispanic Blacks and Hispanics, are less likely
to have cardiac invasive procedures and have higher AMI
mortality compared to non-Hispanic Whites. However,
little is known about inpatient AMI mortality of Asians
residing in the US due to limited numbers of national data
that identify Asians (e.g. the National Health and Nutrition Examination Survey only started to identify Asians
starting 2011).
Asian Americans (henceforth referred to as Asians), including Pacific Islanders, make up 4.8% of the US population and the population has been growing faster than the
national rate [22]. Overall, Asians in the population have a
relatively low prevalence of AMI-related comorbidities, including obesity, diabetes, smoking, and hypertension
[23–26] and a relatively low national AMI mortality
rate (age-adjusted AMI mortality rate from death certificate for non-Hispanic White men was 196.7/
100,000 population and Asian men was 109.1/100,000
population in 1998) [27]. Despite studies that have
examined health disparities involving Asians for other
medical conditions such as stroke [28, 29], previous
research looking at racial/ethnic disparities in AMI
outcomes is limited. Many AMI studies have focused
on non-Asian minorities in the US or involved Asians
residing in Asian countries [29–32]. These studies
showed mixed results, ranging from no differences to
significant differences in outcomes.
To address the gaps in the literature on differences in
AMI outcomes among Asian Americans and to provide
updates in national AMI outcomes, we investigated the
following research questions using comprehensive data
from 10 states that together account for over 70% of the
national Asian American (Asian) population: [1] Are there
differences in observed AMI inpatient mortality
between each of the minority groups (Asians, Blacks,
or Hispanics) and Whites? [2] What is the riskadjusted inpatient AMI mortality of minorities compared to Whites? [3] What are the sociodemographic
and clinical characteristics associated with inpatient
AMI mortality? By answering these questions, we
want to understand racial/ethnic differences in inpatient AMI mortality as well as identify characteristics that are associated with differences in AMI
inpatient mortality.
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Methods
Study population

Our primary data was the 2010–2011 state inpatient
discharge data, containing all patient discharges at nonfederal short-term acute hospitals, from 10 US states California, Florida, Illinois, Massachusetts, Maryland,
New Jersey, New York, Pennsylvania, Texas, and
Virginia. These states were selected based on having
sizable Asian populations and the completeness of
race/ethnicity reporting in the discharge data. Data
for California, Texas, Illinois, Pennsylvania, Massachusetts, and Virginia were obtained from the respective
state agencies [33], and data for remaining states were
obtained from AHRQ HCUP Central Distributor [34].
The data was built and designed after the Feng et al. paper
[35]. The selected 10 states contained 70% of the national
Asian population (Appendix 1). We identified all discharges for adult patients aged 18 and older with the principal diagnosis of AMI (ICD-9: 410) [36]. We excluded
64,561 patients who were transferred to another shortterm hospital, admitted with obstetric-related conditions,
and missing key variables (discharge disposition, gender,
age, discharge quarter/year, principal diagnosis, or admission information) [37].
Race/ethnicity

We used self-reported race/ethnicity and categorized
patients into the following race/ethnicity groups:
Hispanics, (non-Hispanic) Whites, (non-Hispanic) Blacks,
(non-Hispanic) Asians, Others or unknown (i.e., missing).
For the subjects with missing race/ethnicity information
(2.6% of the study population), race/ethnicity was reassigned using the “hot-deck” statistical imputation
method [38]. This method randomly assigns race/ethnicity for patients with missing race/ethnicity in the
same proportion as the race/ethnicity distribution for
those with known race/ethnicity. As previous studies
have indicated that Others include a sizable proportion of Whites, we grouped Others with Whites in all
the analyses [39].
Covariates

Based on previous studies, we identified key demographics, comorbidities, types of AMI, and use of invasive cardiac procedures that were associated with
AMI mortality. Socio-demographic variables included
sex, age, and state of residence [17, 40–44]. We categorized age into seven groups: 18–34, 35–44, 45–54,
55–64, 65–74, 75–84, and 85+. We used Elixhauser
categories to identify comorbidities and determined
whether the patient had the comorbid condition or
not (comorbid conditions include congestive heart
failure, cardiac arrhythmias, valvular disease, pulmonary circulation disorders, peripheral vascular disease,
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hypertension, paralysis, other neurological disorders,
chronic pulmonary disease, diabetes (uncomplicated),
diabetes with chronic complications, hypothyroidism,
renal failure, liver disease, peptic ulcer disease without
bleeding, acquired immune deficiency syndrome,
lymphoma, metastatic cancer, solid tumor without
metastasis, rheumatoid arthritis/collagen vascular
diseases, coagulopathy, obesity, weight loss, fluid and
electrolyte disorders, blood loss anemia, deficiency
anemias, alcohol abuse, drug abuse, psychoses,
depression) [45]. Using secondary diagnosis codes
reported in the index discharge records, the Elixhauser method identifies 30 risk groups associated with
inpatient mortality; these are defined as 30 separate
indicator (0/1) fields. For types of AMI, we differentiated AMI cases into non-ST-segment elevation
(NSTEMI) (ICD-9 = 410.7) and ST-segment elevation MI
(STEMI) (all ICD-9 = 410 excluding 410.7). We used diagnosis and procedure codes from the International Classification of Diseases, Ninth Revision, Clinical modification
and corresponding Current Procedural Terminology to
code for the invasive cardiac procedures of coronary
artery bypass surgery (CABG) and percutaneous coronary
intervention (PCI) [36].
Primary outcome: Inpatient acute MI mortality

The main outcome was inpatient mortality from a
hospitalization for AMI (ICD-9: 410). This is one of the
Inpatient Quality Indicators measured by the Agency for
Healthcare Research and Quality (AHRQ) [37].
Statistical analysis

Statistical analysis was conducted using SAS software,
version 9.3 (SAS Institute Inc., Cary, NC). We
performed descriptive analysis of socio-demographic
characteristics, medical comorbidities, and types of AMI
based on patients’ race/ethnicity. We performed chisquare and t-tests to compare differences between each
of the minority groups and Whites. Next, we examined
use of PCI and CABG for overall AMI, and then among
those with STEMI and NSTEMI.
We used multivariable logistic regression models to
study differences in inpatient mortality among racial/
ethnic minorities (Asians, Hispanics, and Blacks) compared to Whites. To better identify the source of differences in inpatient mortality, we estimated odds ratios in
a sequence of models, adjusting for a wider array of covariates in the following order: age, gender, geographical
location (state), co-morbidities (Elixhauser categories),
type of AMI, and invasive cardiac procedures (CABG
and PCI). We did not correct for multiple testing. Sensitivity analyses were performed to examine disparities in
AMI mortality among those who were transferred from
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another short-term hospital, since this subgroup of
patients may be systematically different in severity.
The Boston University Institutional Review Board
approved this study.

Results
We identified 561,041 AMI cases. Of these, we
excluded 62,267 (11.1%) AMI admissions that were
transferred to another hospital as we do not have information regarding their health outcomes (percentages of each racial/ethnic groups excluded: Asians =
14.5%, White = 10.9%, Black = 11.3%, and Hispanics =
11.3%). In addition, we excluded 2302 (0.4%) AMI
cases with obstetric-related conditions or missing key
variables. The study sample included 496,472 AMI
cases.
Socio-demographic characteristics

Table 1 shows the characteristics of the total sample
as well as subgroups of the different racial/ethnic
groups. The majority of the study population were
White (75%), followed by 12% Hispanics, 10% Black,
and 3% Asian. There was a significant difference in
mean age and percentages of women in different racial/ethnic groups (ANOVA; p-value < 0.01 for both).
Mean average age was the oldest for White (mean
age = 69.4 years old) and the youngest for Black
(mean age = 63.8 years old). Significantly higher percentage of Black patients (48.0%) and lower percentage of Asian patients (35.2%) were women compared
to Whites (39.4%) (p-values< 0.05). There were wide
variations in racial/ethnic composition in each of the
10 states.

Clinical characteristics

We examined the prevalence of each of the comorbidities in the Elixhauser comorbidity index (Table 2).
Compared to Whites, Asians had a mixed profile of
comorbid conditions, with lower prevalence of some
conditions (obesity, cardiac arrhythmia, and peripheral vascular disease), but higher prevalence of a
wider range of conditions (congestive heart failure,
diabetes, hypertension, renal failure, and coagulopathy) (all p-values were less than 0.01). There were
significant racial/ethnic differences in the average
length of stay and number of Elixhauser comorbidity
diagnoses (ANOVA; both p-value < 0.01). Among
different groups, each of the minority groups had
longer average length of stay and Blacks had the
highest average number of diagnoses (11.6 diagnoses)
compared to Whites (Table 3).
Next, we differentiated type of AMI; there were
337,849 (68.0%) hospitalizations for NSTEMI and
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Table 1 Socio-demographic characteristics of AMI hospitalizations by race/ethnicitya*
Variable

All (n = 496,472)

Asian (n = 14,977)

White (n = 372,556)

Black (n = 51,403)

Hispanic (n = 57,536)

68.3 (14.7)

67.2 (14.5)

69.4 (14.5)

63.8 (14.6)*

65.3 (14.4)*

18–34

0.8

1.0

0.6

1.7

1.4

35–44

4.3

5.1

3.7

6.9

5.9

45–54

14.3

14.6

13.2

19.8

17.0

55–64

22.0

22.9

21.1

25.1

24.5

65–74

21.4

22.2

21.2

21.1

22.2

75–84

21.3

20.9

22.4

16.4

19.0

85+

15.9

13.3

17.9

9.0

10.0

40.0

35.2*

39.4

48.0*

37.7

California

n = 92,285

9.6

63.6

7.2

19.6

Florida

n = 78,753

0.7

75.8

9.4

14.1

Illinois

n = 39,950

2.0

78.1

14.1

5.8

Massachusetts

n = 23,176

1.7

90.2

4.0

4.0

Maryland

n = 15,523

1.9

72.5

24.0

1.6

New Jersey

n = 29,662

3.0

76.8

11.3

8.8

New York

n = 59,521

2.7

78.9

10.7

7.8

Pennsylvania

n = 57,160

0.5

89.8

7.8

2.0

Texas

n = 74,553

1.3

66.3

10.9

21.6

Virginia

n = 25,889

1.6

67.6

18.3

1.5

Age
Mean age, years old (SD)
Age groups (%)

Gender
Women (%)
State of residence** (%)

a

Values are means (standard deviation) or percentages of patients
*P-value< 0.05 when each of the racial/ethnic group (Asian, White, or Black) was compared to White
**Racial/ethnic distribution in each state

Table 2 Prevalence of co-morbidities (Elixhauser comorbidities) by race/ethnicity
Variable

Asian
(n = 14,977)

White
(n = 372,556)

Black
(n = 51,403)

Hispanic
(n = 57,536)

% of AMI hospitalizations with the comorbidities
Congestive heart failure

34.5

31.9

35.5

32.0*

Cardiac arrhythmias

36.5

39.5

31.8

31.3

Peripheral vascular disease

9.4

11.3

11.2*

10.6

Hypertension

75.7

70.5

82.4

75.9

Chronic pulmonary disease

13.6

20.5

18.5

14.9

Diabetes, uncomplicated

33.6

26.4

34.1

38.8

Diabetes with chronic complications

11.7

5.7

9.0

10.3

Renal failure

26.6

18.3

28.1

22.0

Coagulopathy

7.4

5.0

4.9*

5.2*

Deficiency anemias

23.1

15.4

21.8

19.4

*P-value ≥ 0.05 when each of the racial/ethnic group (Asian, White, or Black) was compared to White (unmarked signify p-value < 0.05)
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Table 3 Clinical characteristics of AMI hospitalizations by race/ethnicitya
Variable

Asian

White

Black

Hispanic

Number of diagnoses (SD)

11.3 (6.2)

11.3 (5.2)

11.6 (5.2)*

10.8 (5.2)*

Length of stay, days (SD)

6.2 (7.4)*

5.3 (17.4)

5.6 (7.0)*

5.9 (19.5)*

STEMI

35.2*

32.7

25.3*

32.1*

NSTEMI

64.8*

67.3

74.7*

67.9*

Types of AMI

Receipt of invasive cardiac procedures
PCI

48.0

48.2

41.0*

47.6*

CABG

10.6*

9.3

6.5*

10.2*

Receipt of invasive cardiac procedures by AMI type
STEMI (n = 158,623)
PCI

69.5

72.1

68.1*

72.2

CABG

8.0*

7.3

5.4*

8.1*

PCI

36.3

36.5

31.9*

35.9*

CABG

12.0*

10.2

6.9*

11.3*

NSTEMI (n = 337,849)

a

Values are means (standard deviation) or percentages of patients
*P-value< 0.05 when each of the racial/ethnic group (Asian, White, or Black) was compared to White

158,623 (32.0%) hospitalizations for STEMI (Table 3).
Significantly higher proportion of Asians (35.2%) had
STEMI and lower proportions of Blacks (25.3%) or Hispanics (32.1%) had STEMI compared to Whites (32.7%)
(p-values < 0.05). We also examined the prevalence of
cardiac procedure use, specifically percutaneous coronary intervention (PCI) and coronary artery bypass
graft (CABG). Among AMI hospitalization by Asians,
48.0% received PCI and 10.6% received CABG; this is
similar for PCI and higher for CABG compared to
Whites. Regardless of type of procedure or AMI,
Blacks had the lowest rate of cardiac procedures during the hospitalization. In regards to mortality after
cardiac procedures (PCI or CABG), Asians had higher

mortality compared to non-Asians (p < 0.01), specifically after PCI (Appendix 2).
Observed inpatient AMI mortality

There were significant differences in observed
inpatient AMI mortality among different racial and
ethnic groups. Asians had the highest observed
inpatient AMI mortality (inpatient mortality Asian =
7.2%; White = 6.3%; Black = 5.4%, and Hispanic = 5.9%).
This finding persisted for both STEMI (inpatient
mortality Asian = 10.4%; White = 9.4%; Black = 9.8%,
and Hispanic = 8.8%) and NSTEMI (inpatient
mortality Asian = 5.4%; White = 4.8%; Black = 3.9%,
and Hispanic = 4.6%).

Table 4 Odds ratio [95% confidence interval] of inpatient AMI mortality associated with race/ethnicity (reference: non-Hispanic White)

Model 1: Unadjusted

Asian

Black

Hispanic

(n = 14,977)

(n = 51,403)

(n = 57,536)

1.16 [1.09–1.23]

0.85 [0.81–0.88]

0.94 [0.91–0.97]

Model 2: Model 1+ Age group

1.27 [1.19–1.35]

1.06 [1.02–1.11]

1.11 [1.07–1.15]

Model 3: Model 2+ Gender

1.27 [1.19–1.35]

1.06 [1.02–1.11]

1.11 [1.07–1.15]

Model 4: Model 3+ Geography (state)

1.21 [1.14–1.30]

1.05 [1.00–1.09]

1.09 [1.05–1.13]

Model 5: Model 4+ Patient comorbidities (Elixhauser grouping)

1.13 [1.06–1.21]

1.04 [1.00–1.09]

1.15 [1.10–1.19]

Model 6: Model 5+ Type of AMI

1.12 [1.04–1.20]

1.12 [1.07–1.17]

1.17 [1.12–1.22]

Model 7: Model 6+ Receipt of PTCA or CABG

1.11 [1.04–1.19]

1.02 [0.98–1.06]

1.14 [1.09–1.19]
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Models of inpatient AMI mortality adjusting for covariates

We examined the racial/ethnic differences in AMI
mortality using a sequence of multivariable logistic
models, cumulatively including covariates from the different domains (Table 4). Model 1 (which only included
race/ethnicity variable) reported higher unadjusted AMI
mortality among Asians (odds ratio (OR) = 1.16 [95% CI:
1.09–1.23]) compared to Whites; in contrast, Blacks (OR
= 0.85 [0.81–0.88]) and Hispanics (OR = 0.94 [0.91–0.97])
had lower mortality. After adjusting for age differences
(model 2), all minority groups (Asian OR = 1.27 [95% CI:
1.19–1.35], Black OR = 1.06 [95% CI: 1.02–1.11], and Hispanic OR = 1.11 [95% CI: 1.07–1.15]) had higher mortality compared to Whites. This trend persisted even
after adjusting for gender, state of residence, and
comorbidities; however, the Asian versus White gap
decreased after accounting for differences in comorbidities (Model 5). When type of AMI was included in the
analysis (Model 6), likelihood of AMI mortality
increased and became significant for Blacks compared
to Whites. In the final model (Model 7), there was a
shift in AMI mortality among Blacks (from OR = 1.12
[1.07–1.17] to OR = 1.02 [95% CI: 0.98–1.06]) when invasive cardiac procedures were included in the model.
Including the cardiac procedure covariate did not
change the significance of AMI mortality of either
Asians (OR = 1.11 [1.04–1.19]) or Hispanics (OR = 1.14
[1.09–1.19]) when compared to Whites. Sensitivity analysis looking at the subgroup of AMI hospitalizations of
patients transferred from another short-term hospital
(n = 81,888) showed no significant difference in inpatient
AMI mortality between minorities and White (Asian
OR = 0.86 [0.68–1.08]; Black OR = 0.94 [0.82–1.08];
and Hispanic OR = 1.02 [0.89–1.16]) after adjusting
for covariates.

Discussion
Using comprehensive AMI discharge data from 10 states
that contains 70% of the U.S. population of Asians, we
found that Asians had the highest observed inpatient
AMI mortality. There were differences in sociodemographic and clinical characteristics among different racial/ethnic groups. In risk-adjusted inpatient mortality,
the extent of the mortality differences was reduced after
adjusting for comorbidities, an indication of higher
prevalence of comorbidities among Asians admitted with
AMI. In the final model adjusting for sociodemographic
characteristics, comorbidities, type of AMI, and invasive
cardiac procedure use, Asians and Hispanics remained
to have increased likelihoods of inpatient mortality compared to Whites.
One plausible explanation for the higher AMI
inpatient mortality among Asians is higher disease burden and severity, specifically among those with elevated
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risk of AMI. As noted, there was a sizable reduction in
the AMI mortality among Asians after adjusting for
observed comorbidities, which indicates higher overall
comorbidity burden. This pattern of higher comorbidity
risk among Asian AMI hospitalizations contrasts with
epidemiologic evidence of lower disease burden among
the general population of Asians [23–26]. The population level death rate from AMI is lower among Asians,
compared to Whites [27]; this is not inconsistent with
our finding of higher mortality among hospitalizations
for AMI, since our study does not take into account the
risk of being hospitalized (for AMI). The higher cardiovascular risk among some Asians may partly be explained by their recent adoption of western diet and
habits in the U.S. as well as worldwide [46, 47]. The shift
in cardiovascular risk factors are associated with acculturation, particularly the number of years residing in the
US [48–50]. Given no significant differences in likelihoods of AMI mortality among those who were transferred from another short-term hospital, disparities are
not due to racial/ethnic differences in the proportion of
patients who were transferred across hospitals. Instead,
disparities were concentrated largely among cases where
patients were treated in the hospitals where they were
initially admitted.
Besides comorbidities, we observed higher AMI
inpatient mortality among Asians who had cardiac procedures. We do not have information regarding decisions behind why patients received cardiac procedures
but the high cardiac procedure rate among Asians might
be due to more advanced or severe cases that require invasive interventions. The higher mortality among those
receiving cardiac procedures needs further examination,
as identifying contributing factors can improve future
outcomes. If the high mortality is due to a high comorbidity burden, future studies should focus on restratifying risk for all AMI patients. However, if the high
mortality is coming from procedure-related complications common among Asians, such as high bleeding risk
after anti-platelet therapy [51–53], then different medical
therapies, such as lower doses of antithrombotic medications, should be used. The absence of data about complications is a limitation of our study, thus we could not
examine this further. Also, Asians with AMI may seek
medical care when cardiac symptoms are severe and
have been present for longer durations. Delays in receiving care have been associated with poor outcomes
[54–56]. In a study that examined AMI patients experiencing symptoms for less than 24 h, there was no
difference in mortality between Asians and Whites
[32]. Our study did not differentiate patients based on
their duration of symptoms, and the high mortality could
have originated from higher inpatient mortality among
Asians with longer duration of symptoms.
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Another explanation is that certain Asian subgroups
are contributing more to the high inpatient AMI mortality. Asians encompass diverse population and studies
have identified heterogeneity in cardiovascular disease
risk factors among Asians by country of origin. For example, previous studies have identified that South Asians
have more cardiovascular risk factors and worse outcomes compared to Whites [57–59]. In addition, another
study found that certain Asian and Hispanic ethnic
groups have significantly lower insurance rates [60] and
it is possible that these small groups of Asians with disadvantageous socioeconomic factors may experience a
significantly greater impact on AMI mortality due to
limited healthcare access and decreased preventive care
visits. Lastly, the presence of language barriers among
Asians with limited English proficiency could contribute to poor health outcomes [61, 62], and possibly
higher AMI mortality.
There are several limitations of this retrospective
observational study. Given our observational data, a
causal relationship cannot be established between
being Asian and increased inpatient AMI mortality.
Due to the nature of secondary, administrative data,
information on clinical patient status is limited. For
example, clinical information regarding duration or
severity of symptoms, admission vitals, EKG findings,
and procedure complications could have provided
further insight. The data also did not include medications, which would have been helpful in understanding race/ethnicity-specific medical management of
AMI, or how clinical decisions were made in obtaining invasive cardiac procedures. Previous research has
shown mixed results as to whether racial differences

existed in decision-making involving invasive cardiac
procedures [14, 63]. We are missing data in some
states on other covariates such as health insurance
status, educational achievement, and household income, which could affect patients’ access and decision
to seek medical care for AMI. Our data also does not
contain acculturation information, which could indirectly provide immigrants’ newly adopted cardiovascular risks. The findings may not be generalizable to
states with small Asian populations, since we only included 10 states with a sizeable Asian population.
Lastly, there has been a significant increase in multiracial populations, especially Asians tied to other
races or ethnicities [22]. For our study, we used selfreported race/ethnicity, which did not identify multiracial patients.

Conclusion
These data are among the first to show that Asian
patients hospitalized with acute myocardial infarction
had higher observed AMI mortality than Black, Hispanic, or White patients. The findings may have been
driven by higher disease severity, heterogeneous riskassociated with Asian subgroups, and delayed medical
care. We observed higher inpatient AMI mortality
among Asians compared to Whites even after adjusting for sociodemographic and clinical characteristics.
With the increasing number of Asians in the US, disparities in AMI mortality will become more significant. Further research should focus on patient-level
details to better understand the heterogeneity of the
Asian population and clinical factors associated with
such disparities.

Appendix 1
Table 5 2010–2011 Census population and crude state-level counts of AMI by race/ethnicity (Age 18+)
Crude state-level counts of AMI

State share (%) of national census population of adults, 2010

State

Asian

White

Black

Hispanics

All

Asian

White

Black

Hispanics

California

8815

58,703

6673

18,094

92,285

33.1%

7.9%

6.1%

27.8%

All
11.9%

New York

1610

46,953

6338

4620

59,521

9.7%

5.8%

8.2%

7.3%

6.4%

Texas

949

49,415

8105

16,084

74,553

6.6%

5.8%

7.6%

18.4%

7.8%

New Jersey

899

22,792

3359

2612

29,662

4.9%

2.6%

3.1%

3.3%

2.9%

Illinois

784

31,217

5648

2301

39,950

4.0%

4.1%

4.8%

3.9%

4.1%

Florida

522

59,677

7423

11,131

78,753

3.1%

5.8%

7.6%

9.4%

6.3%

Virginia

425

20,340

4744

380

25,889

3.0%

2.6%

4.1%

1.3%

2.6%

Massachusetts

398

20,912

936

930

23,176

2.4%

2.6%

1.1%

1.2%

2.2%

Maryland

295

11,248

3731

249

15,523

2.2%

1.6%

4.5%

1.0%

1.9%

Pennsylvania

280

51,299

4446

1135

57,160

2.4%

5.2%

3.5%

1.4%

4.2%

Total

14,977

372,556

51,403

57,536

496,472

76.0%

50.4%

52.6%

84.6%

56.8%
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Appendix 2
Table 6 Percentage of patients receiving invasive cardiac
procedure treatment for AMI and their observed inpatient
mortality
Variable

Asian

White

Black

Hispanic

P-value*

PCI or CABG

57.6%

56.5%

47.0%

56.8%

< 0.01

Mortality

3.7%

3.1%

2.9%

3.4%

< 0.01

48.0%

48.2%

41.0%

47.6%

0.09

3.6%

3.0%

2.7%

3.4%

0.01

10.6%

9.3%

6.5%

10.2%

< 0.01

4.6%

3.9%

4.6%

3.4%

0.15

AMI (n = 496,472)

PCI
Mortality
CABG
Mortality

*Comparing Asians versus non-Asians (combined non-Hispanic White,
non-Hispanic Black, and Hispanic)

Abbreviations
AHRQ: Agency for Healthcare Research and Quality; AMI: Acute myocardial
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elevation myocardial infarction; OR: Odds ratio; PCI: Percutaneous coronary
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